Neurologist and scientist Justin Zivin helped develop and champion the use of tPA, a clot-busting drug that can minimize the impact of stroke on its victims. One day in late 2009, neurologist Boris ...

Patients with acute stroke benefit from thrombolysis with IV tissue plasminogen activator (tPA). In the last decade, a number of endovascular techniques have increasingly been used to open blood ...

All potential acute ischemic stroke patients meeting criteria for the use of IV tPA should be offered treatment. The facts are clear, and all that remains is further provider and patient education.

Ischaemic stroke can lead to permanent neurological damage and often death if not diagnosed and treated promptly. There is therefore an urgent need for novel treatment approaches. Now, writing in ...